scispace - formally typeset
Open AccessJournal ArticleDOI

Outcomes in Advanced Heart Failure Patients with Left Ventricular Assist Devices for Destination Therapy

Reads0
Chats0
TLDR
The benefit of DT therapy with the HMII is confirmed in subsequent trial patients, with improved adverse event rates and a strong trend for improvements in survival.
Abstract
Background—The HeartMate II (HMII) destination therapy (DT) trial demonstrated significant improvements in outcomes in continuous-flow left ventricular assist devices compared with patients implant...

read more

Citations
More filters
Journal ArticleDOI

Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.

TL;DR: In this trial involving patients with advanced heart failure who were ineligible for heart transplantation, a small, intrapericardial, centrifugal‐flow LVAD was found to be noninferior to an axial‐ flow LVAD with respect to survival free from disabling stroke or device removal for malfunction or failure.
Journal ArticleDOI

Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.

TL;DR: A unique ramp test protocol to be routinely used at the time of discharge for speed optimization and/or if device malfunction was suspected and may be used to monitor the effects of therapeutic interventions and need for surgical intervention in CF-LVAD patients.
References
More filters
Related Papers (5)